Cancer - A Story on Fault Propagation in Gene-Cellular Networks

We discuss problems related to propagation phenomena in biological networks. As an example we consider processes leading to carcinogenesis and development of cancer, seen as a complex genetic disease from a system theoretic point of view. We present particular regulatory mechanisms which make the cell cycle a fault tolerant system. Then we indicate weak points in this system leading to mutagenesis and cancer progression. The next stage in this cascade of events is related to an angiogenic switch, which in turn may be treated as a trigger of metastasis. All these processes result from communication, competition and subordination between normal and cancer cells. We illustrate interaction processes by models based on evolutionary games and spatial evolutionary games, which describe propagation phenomena in time and space.

[1]  Kurt W. Kohn,et al.  Genomic Instability and DNA Repair , 2005 .

[2]  D. Häder,et al.  UV-induced DNA damage and repair: a review , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[3]  Joanna Polanska,et al.  Efficient Algorithm for Microarray Probes Re-annotation , 2011, ICCCI.

[4]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[5]  Niko Beerenwinkel,et al.  Evolutionary Games with Affine Fitness Functions: Applications to Cancer , 2011, Dyn. Games Appl..

[6]  Krzysztof Puszynski,et al.  Prediction of the Behavior of Mammalian Cells after Exposure to Ionizing Radiation Based on the New Mathematical Model of ATM-Mdm2-p53 Regulatory Pathway , 2014 .

[7]  T. Glisovic,et al.  RNA‐binding proteins and post‐transcriptional gene regulation , 2008, FEBS letters.

[8]  H. Neurath,et al.  Role of proteolytic enzymes in biological regulation (a review). , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Faller,et al.  Targeting the RAS oncogene , 2013, Expert opinion on therapeutic targets.

[10]  Roman Jaksik,et al.  MicroRNAs and reactive oxygen species: are they in the same regulatory circuit? , 2014, Mutation research. Genetic toxicology and environmental mutagenesis.

[11]  R. Veitia,et al.  Transcription factors: specific DNA binding and specific gene regulation. , 2014, Trends in genetics : TIG.

[12]  F. C. Santos,et al.  Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells , 2009, British Journal of Cancer.

[13]  Mats Nilsson,et al.  DNA repair genes are selectively mutated in diffuse large B cell lymphomas , 2013, The Journal of experimental medicine.

[14]  Kevin V. Urbano Advances in Genetics Research , 2017, Stem Cell Research International.

[15]  Karl Munger,et al.  The papillomavirus E7 proteins. , 2013, Virology.

[16]  C. Maley,et al.  Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .

[17]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[18]  Lei Xu,et al.  Normalization of the vasculature for treatment of cancer and other diseases. , 2011, Physiological reviews.

[19]  J. Pietenpol,et al.  Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. , 2002, Toxicology.

[20]  R. Jaksik,et al.  Calculation of reliable transcript levels of annotated genes on the basis of multiple probe-sets in Affymetrix microarrays. , 2009, Acta biochimica Polonica.

[21]  Roman Jaksik,et al.  Autophagy, Apoptosis, Mitoptosis and Necrosis: Interdependence Between Those Pathways and Effects on Cancer , 2013, Archivum Immunologiae et Therapiae Experimentalis.

[22]  U. Moll,et al.  The MDM2-p53 interaction. , 2003, Molecular cancer research : MCR.

[23]  A. Świerniak,et al.  Mathematical modeling as a tool for planning anticancer therapy. , 2009, European journal of pharmacology.

[24]  Yan Tang,et al.  Altered p16INK4 and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer , 2012, Journal of oncology.

[25]  E. Wang,et al.  Genetic studies of diseases , 2007, Cellular and Molecular Life Sciences.

[26]  R. Jain Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[27]  W. El-Deiry,et al.  p21WAF1 and tumourigenesis: 20 years after , 2013, Current opinion in oncology.

[28]  Roman Jaksik,et al.  The distribution of GC nucleotides and regulatory sequence motifs in genes and their adjacent sequences. , 2012, Gene.

[29]  María Martín,et al.  Activities at the Universal Protein Resource (UniProt) , 2013, Nucleic Acids Res..

[30]  Melissa J. Landrum,et al.  RefSeq: an update on mammalian reference sequences , 2013, Nucleic Acids Res..

[31]  T. Vincent,et al.  An evolutionary model of carcinogenesis. , 2003, Cancer research.

[32]  T. de Ravel,et al.  Clinical and molecular aspects of RAS related disorders , 2008, Journal of Medical Genetics.

[33]  Marek Kimmel,et al.  Model-based analysis of interferon-beta induced signaling pathway , 2008, Bioinform..

[34]  Masahiro Okamoto,et al.  Mathematical modeling of cell cycle regulation in response to DNA damage: Exploring mechanisms of cell-fate determination , 2011, Biosyst..

[35]  Andrzej Swierniak,et al.  GAME THEORETIC APPROACH TO MATHEMATICAL MODELING OF RADIATION INDUCED BYSTANDER EFFECT , 2010, BioMed 2010.

[36]  Marco Foiani,et al.  Regulation of DNA repair throughout the cell cycle , 2008, Nature Reviews Molecular Cell Biology.

[37]  Alberto Gandolfi,et al.  Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular "pruning". , 2010, Journal of theoretical biology.

[38]  L. Cantley,et al.  New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Eileen White,et al.  Exploiting the bad eating habits of Ras-driven cancers , 2013, Genes & development.

[40]  J. Folkman Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[41]  Jinqian Zhang,et al.  The risk factor of gallbladder cancer: hyperplasia of mucous epithelium caused by gallstones associates with p16/CyclinD1/CDK4 pathway. , 2011, Experimental and molecular pathology.

[42]  S. Lowe,et al.  Tumor suppressive functions of p53. , 2009, Cold Spring Harbor perspectives in biology.

[43]  E. Pietka,et al.  Information Technologies in Biomedicine , 2008 .

[44]  U. Moll,et al.  Links between mutant p53 and genomic instability , 2012, Journal of cellular biochemistry.

[45]  Oliver Gautschi,et al.  Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. , 2007, Lung Cancer.

[46]  Dariusz Król Propagation Phenomenon in Complex Networks: Theory and Practice , 2014, New Generation Computing.

[47]  Yihui Fan,et al.  NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer , 2013, Protein & Cell.

[48]  Y. Shiloh ATM and related protein kinases: safeguarding genome integrity , 2003, Nature Reviews Cancer.

[49]  Gerhard Christofori,et al.  The angiogenic switch in carcinogenesis. , 2009, Seminars in cancer biology.

[50]  Alissa M. Weaver,et al.  Microenvironmental independence associated with tumor progression. , 2009, Cancer research.

[51]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[52]  Nicola Bellomo,et al.  Selected topics in cancer modeling : genesis, evolution, immune competition, and therapy , 2008 .

[53]  G. Cooper The Cell: A Molecular Approach , 1996 .

[54]  Shalom Madar,et al.  Mutant p53 gain of function is interwoven into the hallmarks of cancer , 2011, The Journal of pathology.

[55]  I. Tomlinson,et al.  Game-theory models of interactions between tumour cells. , 1997, European journal of cancer.

[56]  A. Ashworth,et al.  The DNA damage response and cancer therapy , 2012, Nature.

[57]  Jean Peccoud,et al.  Measurement and modeling of transcriptional noise in the cell cycle regulatory network , 2013, Cell cycle.

[58]  E. Ben-Jacob,et al.  Bacterial survival strategies suggest rethinking cancer cooperativity. , 2012, Trends in microbiology.

[59]  H. Ohtsuki,et al.  Accumulation of driver and passenger mutations during tumor progression , 2009, Proceedings of the National Academy of Sciences.

[60]  David Basanta,et al.  The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view , 2011, Physical biology.

[61]  Roberto Natalini,et al.  The p53 protein and its molecular network: modelling a missing link between DNA damage and cell fate. , 2014, Biochimica et biophysica acta.

[62]  Thomas S Deisboeck,et al.  Evolutionary game theory in an agent-based brain tumor model: exploring the 'Genotype-Phenotype' link. , 2006, Journal of theoretical biology.

[63]  Joanna Polanska,et al.  Bystander effects induced by medium from irradiated cells: similar transcriptome responses in irradiated and bystander K562 cells. , 2010, International journal of radiation oncology, biology, physics.

[64]  Roman Jaksik,et al.  Position weight matrix model as a tool for the study of regulatory elements distribution across the DNA sequence , 2010 .

[65]  L. Johnson The regulation of protein phosphorylation. , 2009, Biochemical Society transactions.

[66]  Roman Jaksik,et al.  Regulation of p53 by siRNA in radiation treated cells: Simulation studies , 2012, Int. J. Appl. Math. Comput. Sci..

[67]  David Basanta,et al.  Exploiting evolution to treat drug resistance: combination therapy and the double bind. , 2012, Molecular pharmaceutics.

[68]  Attila Tóth,et al.  Cell cycle regulation by feed-forward loops coupling transcription and phosphorylation , 2009, Molecular systems biology.

[69]  Hirohisa Yano,et al.  Angiogenesis in Cancer , 2006, Vascular health and risk management.

[70]  Andrzej Swierniak,et al.  Application of evolutionary games to modeling carcinogenesis. , 2013, Mathematical biosciences and engineering : MBE.

[71]  J. R. Pomerening,et al.  Positive‐feedback loops in cell cycle progression , 2009, FEBS letters.

[72]  J. C. FISHER,et al.  Multiple-Mutation Theory of Carcinogenesis , 1958, Nature.

[73]  Ziqiang Yuan,et al.  Mutations in CDKN2C (p18) and CDKN2D (p19) may cause sporadic parathyroid adenoma. , 2013, Endocrine-related cancer.

[74]  H. Cha,et al.  The accumulation of DNA repair defects is the molecular origin of carcinogenesis , 2013, Tumor Biology.

[75]  M. Kimmel,et al.  Reaction-diffusion approach to modeling of the spread of early tumors along linear or tubular structures. , 2007, Journal of theoretical biology.

[76]  John J Tyson,et al.  Functional motifs in biochemical reaction networks. , 2010, Annual review of physical chemistry.

[77]  Krzysztof Fujarewicz,et al.  Adjoint Systems for Models of Cell Signaling Pathways and their Application to Parameter Fitting , 2007, TCBB.

[78]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[79]  Joanna Polanska,et al.  Adaptive filtering of microarray gene expression data based on Gaussian mixture decomposition , 2013, BMC Bioinformatics.

[80]  M. Nowak,et al.  Evolutionary game theory , 1995, Current Biology.

[81]  T. Hemnani,et al.  Reactive oxygen species and oxidative DNA damage. , 1998, Indian journal of physiology and pharmacology.

[82]  L. Yip,et al.  RAS mutations in thyroid cancer. , 2013, The oncologist.

[83]  Masahiro Okamoto,et al.  Mechanism of cell cycle disruption by multiple p53 pulses. , 2011, Genome informatics. International Conference on Genome Informatics.

[84]  Tomasz Lipniacki,et al.  Oscillations and bistability in the stochastic model of p53 regulation. , 2008, Journal of theoretical biology.

[85]  J M Smith,et al.  Evolution and the theory of games , 1976 .

[86]  W. F. Bodmer,et al.  Modelling the consequences of interactions between tumour cells. , 1997, British Journal of Cancer.

[87]  P. Jeggo,et al.  Radiosensitivity in Nijmegen Breakage Syndrome cells is attributable to a repair defect and not cell cycle checkpoint defects. , 2000, Cancer research.

[88]  K. Shannon,et al.  Targeting oncogenic Ras signaling in hematologic malignancies. , 2012, Blood.

[89]  Joanna Polanska,et al.  Affymetrix Chip Definition Files Construction Based on Custom Probe Set Annotation Database , 2011 .

[90]  W. Bodmer,et al.  Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[91]  Varda Rotter,et al.  When mutants gain new powers: news from the mutant p53 field , 2009, Nature Reviews Cancer.

[92]  Joanna Polanska,et al.  Sources of High Variance between Probe Signals in Affymetrix Short Oligonucleotide Microarrays , 2014, Sensors.

[93]  Heinz Höfler,et al.  Open Access Research Characterization of a Naturally-occurring P27 Mutation Predisposing to Multiple Endocrine Tumors , 2022 .

[94]  Andrzej Świerniak,et al.  Spatial evolutionary games and radiation induced bystander effect , 2011 .

[95]  A. Levine,et al.  The p53 pathway: positive and negative feedback loops , 2005, Oncogene.

[96]  Lance A. Liotta,et al.  Cancer: Out of air is not out of action , 2003, Nature.

[97]  K. Fujarewicz Planning identification experiments for cell signaling pathways: An NFκB case study , 2010, Int. J. Appl. Math. Comput. Sci..

[98]  Douglas Hanahan,et al.  Loss of p19Arf Facilitates the Angiogenic Switch and Tumor Initiation in a Multi-Stage Cancer Model via p53-Dependent and Independent Mechanisms , 2010, PloS one.

[99]  Varda Rotter,et al.  Transcriptional control of the proliferation cluster by the tumor suppressor p53. , 2010, Molecular bioSystems.

[100]  B. Zetter,et al.  Angiogenesis and tumor metastasis. , 1998, Annual review of medicine.

[101]  J. Alsner,et al.  An evolutionary-game model of tumour-cell interactions: possible relevance to gene therapy. , 2001, European journal of cancer.

[102]  Hermann Einsele,et al.  Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival. , 2011, Blood.

[103]  J. M. Smith,et al.  The Logic of Animal Conflict , 1973, Nature.

[104]  Michael Karin,et al.  NF-kappaB and cancer-identifying targets and mechanisms. , 2008, Current opinion in genetics & development.

[105]  H. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[106]  D. Yamazaki,et al.  Regulation of cancer cell motility through actin reorganization , 2005, Cancer science.

[107]  D. Klimstra,et al.  p16 Stimulates CDC42-Dependent Migration of Hepatocellular Carcinoma Cells , 2013, PloS one.

[108]  L. Loeb,et al.  Mutator phenotype may be required for multistage carcinogenesis. , 1991, Cancer research.

[109]  Ivan Mijakovic,et al.  Protein phosphorylation from the perspective of systems biology. , 2012, Current opinion in biotechnology.

[110]  Andreas Deutsch,et al.  A Game Theoretical Perspective on the Somatic Evolution of cancer , 2008, 0810.4738.

[111]  Kyle Summers,et al.  Evolutionary biology of cancer. , 2005, Trends in ecology & evolution.

[112]  E. Voest,et al.  Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches , 2002, Molecular and Cellular Endocrinology.

[113]  Lars A. Bach,et al.  Spatial Evolutionary Games of Interaction among Generic Cancer Cells , 2003 .